My mother has been diagnosed with breast cancer, and I’m helping with her medical appointments. Her oncologist says she needs a liquid biopsy. She has already had a ...

The global breast biopsy market is anticipated to grow at a steady CAGR of 5.5% during the forecast period 2020-2026, according to a report by Gen Consulting Company.

The global Breast Biopsy Devices Market is projected to be valued at USD 2.47 billion in 2025 and is expected to reach USD 4.21 billion by 2035, registering a CAGR of 5.5% during the forecast period.

GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform ...

In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more ...

A patch containing tens of millions of microscopic nanoneedles could soon replace traditional biopsies, scientists have found ...

The global Cancer Biopsy Market encompasses a wide array of diagnostic tools—from traditional tissue biopsy needles and core ...

A traditional tissue biopsy comes with risks and challenges—the target area can be hard to reach and bleeding and pain can last up to a month afterward. Patients can expect steep medical bills ...

MRI-guided core biopsy. MRI imaging is used to direct the placement of a needle into the area of breast tissue to be biopsied. Tissue samples are taken through the needle.

A core needle biopsy, which involves using a hollow needle to remove a small piece of prostate tissue called “a core,” is the primary method of diagnosing prostate cancer.